CREO MEDICAL GROUP PLC – H1 26 Trading Update
RNS Number : 0550O Creo Medical Group PLC 28 July 2026 Creo Medical Group plc (“Creo”, the “Company”
RNS Number : 0550O Creo Medical Group PLC 28 July 2026 Creo Medical Group plc (“Creo”, the “Company”
RNS Number : 4630N Creo Medical Group PLC 23 July 2026 Creo Medical Group plc (“Creo”, the “Company”
RNS Number : 0269K Creo Medical Group PLC 29 June 2026 Creo Medical Group plc (“Creo”, the “Company” or
RNS Number : 8875G Creo Medical Group PLC 04 June 2026 Creo Medical Group plc (“Creo”, the “Company” or
RNS Number : 6595A Creo Medical Group PLC 16 April 2026 Creo Medical Group plc (“Creo”, the “Company”
Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that trading for the year ended 31 December 2020 was marginally ahead of management expectations, with revenue for the year ended 31 December 2020 increasing to over £9m (2019: £0.01m). The Company had a net cash position at 31 December 2020 in excess of £45m.
Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of surgical endoscopy, announces the following change to the Board and strengthening of the Senior Management team.
Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces its audited results for the 12 months ended 31 December 2019.
Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, provides an update on trading.
Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that trading for the year ended 31 December 2019 has been in-line with expectations and the Company continues to make progress in the commercialisation of the CROMA Advanced Energy Platform (“CROMA”) and a suite of patented electrosurgical devices.